Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Dumping 20M shares and keeping 10M warrants @$3.18

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Jan 28, 2021 11:27am

140 Views

Post# 32409552

RE:RE:RE:RE:RE:RE:RE:Dumping 20M shares and keeping 10M warrants @$3.18

He does, but I don't think that is anything of great importance. The problem is the deal came too early, raised more money than they needed (given the catalysts for the share price directly ahead) had horrible terms and was done via Canadian brokers versus trying to expand their footprint among US brokers using the leverage of a deal.

Does it really matter if NBF got a small portion of the offering versus more to Mackie or Canaccord? Not much.

That being said, I was pretty schocked to see NBF being part of the deal as the analyst there has hardly been supportive of TH lately. So, maybe Dubuc was helping some old friends a little. If so, it is nice to see he has loyalty to someone - too bad it couldn't have been us.

jeffm34 wrote:
The CFO Dubuc has ties to NBF one of the beneficiaries

balmusette wrote: Eventualy it would be interesting to see if those who benefited from this deal ( especialy the large position buyers ) are friends or connected with some members of the board.